Tickerplace logo

Tickerplace

Cytek Biosciences, Inc. logo

CTKBCytek Biosciences, Inc.

CTKB Stock Price, Valuation & Chart | Cytek Biosciences, Inc.

Compare
$5.250-0.16 (-2.96%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Medical - Devices
OverviewFinancialsDividendsRatios

CTKB Historical price chart

CTKB Key Stats

Market Capitalization682.41M
PE Ratio-27.81
EPS-0.19
Trading Volume1.05M
Today's High/Low5.43/5.21
Dividend Yield0.00
52 Week High/Low6.21/3.31
Shares Outstanding129.98M
CTKB Financial Statement
CTKB Analyst ratings
CTKB Analysis & performance metrics

CTKB Company profile

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical…

CTKB Management team

Management
Valerie T. Barnett J.D.
Chief Legal Officer & Corporate Secretary
Ming Yan Ph.D.CTO
Chief Technology Officer & Director
William D. McCombeCFO
Chief Financial Officer
Patrik Sebastian Jeanmonod
Head of Corporate Development Analytics
Philippe Busque Ph.D.
Senior Vice President of Global Sales & Services
Allen B. Poirson Ph.D.
Senior Vice President of Business & Corporate Development
Wenbin Jiang Ph.D.CEO
President, Chief Executive Officer & Chairman of the Board
Total 7 executives

CTKB Frequently asked questions

What is Cytek Biosciences, Inc. (CTKB) Stock Price?

Current stock price of Cytek Biosciences, Inc. (CTKB) stock is $5.250. The stock price is -2.96% lower in the session. The intraday range can be seen from this page. Volume of Cytek Biosciences, Inc. (CTKB) stock is 1.05M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Cytek Biosciences, Inc. (CTKB) stock price going up or down today?

The stock price of Cytek Biosciences, Inc. (CTKB) can change with earnings, company news, and overall market sentiment. Cytek Biosciences, Inc. operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cytek Biosciences, Inc. stock expensive at its current price?

Whether Cytek Biosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CTKB on this page is -27.81. EPS on this page is -0.19. Compare those figures with peers and growth expectations before deciding if the current Cytek Biosciences, Inc. price is justified.

How has the stock price of Cytek Biosciences, Inc. (CTKB) performed historically?

Historical performance for Cytek Biosciences, Inc. (CTKB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CTKB reacted to past earnings and market events.

Should I buy Cytek Biosciences, Inc. (CTKB) stock, at this price?

Buying Cytek Biosciences, Inc. (CTKB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.